Publications by authors named "Eva Gaarsdal"

Claim this Profile
C
Circulating tumor necrosis factor-α and YKL-40 level is associated with remission status following salvage therapy in relapsed non-Hodgkin lymphoma.
Tarec C El-Galaly, Anders E Bilgrau, Eva Gaarsdal, Tobias W Klausen, Lars M Pedersen

Leuk Lymphoma· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Mobilisation of haematopoietic stem cells with plerixafor--secondary publication].
Per Boye Hansen, Eva Gaarsdal

Ugeskr Laeger· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Stem cell harvesting after plerixafor treatment].
Per Boye Hansen, Eva Gaarsdal

Ugeskr Laeger· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers.
Inge Marie Svane, Anders E Pedersen, Julia S Johansen, Hans E Johnsen, Dorte Nielsen, Eva Gaarsdal

Cancer Immunol Immunother· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study.
Inge Marie Svane, Anders E Pedersen, Hans E Johnsen, Dorte Nielsen, Claus Kamby, Eva Gaarsdal

Cancer Immunol Immunother· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of CD34-selected and CD19-depleted autografting in multiple myeloma patients: a pilot study.
Thomas Rasmussen, Bosse Björkstrand, Heidi Andersen, Eva Gaarsdal, Hans Erik Johnsen

Exp Hematol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis